Emerging and High Growth Companies

Biossil Inc. in its US$43-million financing round Biossil Inc. in its US$43-million financing round

Biossil Inc.

Home About Us Representative Work

Expertise
Emerging and High Growth Companies Pharmaceuticals and Life Sciences
Key Contact
Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Team
Gary Marshall

Partner, Emerging and High Growth Companies, Toronto

On April 21, 2026, Biossil Inc. announced its US$43-million financing round co-led by Founders Fund and OpenAI. The financing will be used to support the company’s mission of offering previously failed drugs a chance to advance to approval at a fraction of traditional cost and time. 

Biossil is an artificial intelligence drug discovery platform founded to develop targeted therapies for biologically defined patient sub-populations.

Osler, Hoskin & Harcourt LLP advised Biossil Inc. with a team consisting of Chad Bayne, Gary Marshall, Mihnea Porime and Hailey Chin (Emerging and High Growth Companies).

Value
US$43 million
Date Announced
April 21, 2026
Lead Office
Toronto
Key Contact
Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Team
Gary Marshall

Partner, Emerging and High Growth Companies, Toronto

RELATED EXPERTISE

Find out how we can help you achieve extraordinary results

We have an undisputed reputation for solving problems, removing obstacles, and providing the answers you need, when you need them.

Work with us

Osler is a leading business law firm practising internationally from offices across Canada and in New York. Our clients include industry and business leaders in all segments of the market and at various stages in the growth of their businesses. We have built our reputation on our commitment to our clients' success and the experience, expertise and collaborative approach for which we are recognized. We believe that our success is a reflection of our clients' success.